| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/07/2009 | EP2011801A1 Immunoconjugates having high binding affinity |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2011514A1 A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 01/07/2009 | EP2011513A1 Therapeutic agents for alzheimer's disease and cancer |
| 01/07/2009 | EP2011510A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 01/07/2009 | EP2011503A2 High affinity nucleic acid ligands of cytokines |
| 01/07/2009 | EP2010680A2 Methods and means for assessing hiv gag/protease inhibitor therapy |
| 01/07/2009 | EP2010675A2 New detector probe acting by molecular recognition |
| 01/07/2009 | EP2010672A1 Formulations and method for isolating nucleic acids from complex starting materials and subsequent complex genetic analysis |
| 01/07/2009 | EP2010664A2 Fermentive production of four carbon alcohols |
| 01/07/2009 | EP2010663A1 Exosome transfer of nucleic acids to cells |
| 01/07/2009 | EP2010662A2 Novel gene disruptions, compositions and methods relating thereto |
| 01/07/2009 | EP2010661A2 Proteins associated with abiotic stress response and homologs |
| 01/07/2009 | EP2010660A2 Compositions and methods for epigenetic modification of nucleic acid sequences in vivo |
| 01/07/2009 | EP2010658A2 Gene therapy for cancer using small interfering rna specific to ant2 and a method to overcome tolerance to antitumor agent |
| 01/07/2009 | EP2010657A2 Use of microarrays for genomic representation selection |
| 01/07/2009 | EP2010656A2 Intracellular method for selecting a peptide or polypeptide which binds to a bait peptide or polypeptide |
| 01/07/2009 | EP2010655A1 Polyhedral nanostructures formed from nucleic acids |
| 01/07/2009 | EP2010651A2 MUTATED TRUNCATED MT-PFKA GENE FOR THE SYNTHESIS OF ACTIVE SHORTER FRAGMENT OF 6-PHOSPHOFRUCTO-l-KINASE |
| 01/07/2009 | EP2010572A1 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
| 01/07/2009 | EP2010567A2 Antibody compositions and methods for treatment of neoplastic disease |
| 01/07/2009 | EP2010565A1 Method for recombinant protein production in cho cells |
| 01/07/2009 | EP2010562A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same |
| 01/07/2009 | EP2010560A2 Active potassium channel transporters (akt) and their use to create stress tolerant plants |
| 01/07/2009 | EP2010226A2 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 01/07/2009 | EP2010225A2 Methods and compositions for targeting c-rel |
| 01/07/2009 | EP2010209A2 Immunogenic wt-1 peptides and methods of use thereof |
| 01/07/2009 | EP2010207A2 Compositions and methods relating to modulation of immune system components |
| 01/07/2009 | EP2009990A2 Methods and compositions related to adenoassociated virus-phage particles |
| 01/07/2009 | EP1963506A4 Compositions and methods for increasing production of recombinant gamma-carboxylated proteins |
| 01/07/2009 | EP1910540A4 Modification of flavonoid biosynthesis in plants |
| 01/07/2009 | EP1902066A4 Il-6 binding proteins |
| 01/07/2009 | EP1828381B1 Template directed split and mix systhesis of small molecule libraries |
| 01/07/2009 | EP1765992A4 Truncated galnact2 polypeptides and nucleic acids |
| 01/07/2009 | EP1740600A4 Intracellular delivery of osteoinductive proteins and peptides |
| 01/07/2009 | EP1711614B1 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/07/2009 | EP1692165B1 High throughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein |
| 01/07/2009 | EP1689872B1 Promoters for expression in modified vaccinia virus ankara |
| 01/07/2009 | EP1675947B1 A method of screening for protein secreting recombinant host cells |
| 01/07/2009 | EP1646724B1 Industrial method for producing rna and system for carrying out said method |
| 01/07/2009 | EP1644492B1 Modified recombinant vaccinia viruses, uses thereof |
| 01/07/2009 | EP1624748A4 A transgenic animal model for cancer and stem cells |
| 01/07/2009 | EP1580556B1 Functional domain and associated molecule of dock2 essentially required in lymphocyte migration |
| 01/07/2009 | EP1578763B1 Process for purification of plasmid dna |
| 01/07/2009 | EP1572893B1 Production of adeno-associated virus in insect cells |
| 01/07/2009 | EP1563091B1 Methods and materials for using chemical compounds as a tool for nucleic acid storage on media of nucleic acid purification systems |
| 01/07/2009 | EP1551868B1 Factor involved in metastasis and uses thereof |
| 01/07/2009 | EP1543032B1 Method for the rational mutagenesis of a/beta t cell receptors and correspondingly mutated mdm2 protein-specific a/beta t-cell receptors |
| 01/07/2009 | EP1532239B1 Methods and compositions for targeting secretory lysosomes |
| 01/07/2009 | EP1505149B1 Methylotroph yeast producing mammalian type sugar chain |
| 01/07/2009 | EP1504030B1 Constitutively translocating cell line |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1442045B1 Isolation and purification of nucleic acids |
| 01/07/2009 | EP1440311B1 Affinity-shifted probes for quantifying analyte polynucleotides |
| 01/07/2009 | EP1436756B1 Polymorphic marker that can be used to assess the efficacy of interferon therapy |
| 01/07/2009 | EP1409684B1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/07/2009 | EP1385545B1 Humanized antibodies recognizing the beta-amyloid peptide |
| 01/07/2009 | EP1317559B1 Dna transfection system for the generation of infectious negative strand rna virus |
| 01/07/2009 | EP1282469B1 System and method for manipulating magnetically responsive particles in fluid samples to collect dna or rna from a sample |
| 01/07/2009 | EP1280894B1 Methods for forming recombined nucleic acids |
| 01/07/2009 | EP1263987B1 Random truncation and amplification of nucleic acid |
| 01/07/2009 | EP1255716B1 Segment synthesis |
| 01/07/2009 | EP1238103B1 Methods for disease detection |
| 01/07/2009 | EP1231895B1 Modular targeted liposomal delivery system |
| 01/07/2009 | EP1220933B1 Purification of recombinant proteins fused to multiple epitopes |
| 01/07/2009 | EP1212423B1 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 01/07/2009 | EP1203087B1 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 01/07/2009 | EP1203077B1 TRANSGENIC PLANTS EXPRESSING i PHOTORHABDUS /i TOXIN |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1198581B1 Method for reducing the antigenicity of adeno-associated virus structural protein |
| 01/07/2009 | EP1127065B1 Chlamydia antigen and corresponding dna fragments and uses thereof |
| 01/07/2009 | EP1124984B1 Host cells expressing recombinant human erythropoietin |
| 01/07/2009 | EP1115874B1 Alzheimer's disease secretase |
| 01/07/2009 | EP1103564B1 Cancer antigens based on tumor suppressor gene wt1 product |
| 01/07/2009 | EP1012293B1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/07/2009 | EP1003879B1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 01/07/2009 | EP0981604B1 Targeted gene modification by parvoviral vectors |
| 01/07/2009 | EP0971693B1 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/07/2009 | EP0966537B1 Fasciola hepatica vaccines |
| 01/07/2009 | EP0870046B1 Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis |
| 01/07/2009 | EP0833944B1 Nucleic acid ligands that bind to and inhibit dna polymerases |
| 01/07/2009 | EP0759985B1 Transgenic arthritic mice |
| 01/07/2009 | EP0721508B1 Receptor-activated reporter systems |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341252A Protein expression in rodent cells |
| 01/07/2009 | CN101341251A Method for the enzymatic production of 5-norbornen-2-carboxylic acid |
| 01/07/2009 | CN101341250A Technique for producing biomass using microbes with broken glucose dehydrogenase gene (GMS 01) |
| 01/07/2009 | CN101341249A Method for detecting microorganism and reagent kit for detecting microorganism |
| 01/07/2009 | CN101341246A The use of sirnas in organ storage/reperfusion solutions |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101341169A Fsh mutants |
| 01/07/2009 | CN101340934A Immuno-RNA-constructs |
| 01/07/2009 | CN101340928A Modified proteases that inhibit complement activation |
| 01/07/2009 | CN101340814A Methods to produce desired proteins in plants |
| 01/07/2009 | CN101338454A Method for constructing membrane protein cDNA library and use thereof |
| 01/07/2009 | CN101338338A Molecule marker of red peel gene of weedy rice |
| 01/07/2009 | CN101338330A Method for synthesizing dTDP-4-amino-4,6- dideoxy-D-glucose, preparation method and use thereof |
| 01/07/2009 | CN101338322A Novel gene vector constructed by high molecular polymer and preparation method |
| 01/07/2009 | CN101338321A Method for constructing and screening miRNAs expression vector of stomach cancer target FUT3 gene and uses thereof |